AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 58 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $13,947,000 | +57.5% | 233,067 | -26.1% | 7.82% | +131.1% |
| Q3 2019 | $8,858,000 | -25.8% | 315,331 | 0.0% | 3.38% | -13.6% |
| Q2 2019 | $11,938,000 | -3.0% | 315,331 | 0.0% | 3.92% | +22.2% |
| Q1 2019 | $12,304,000 | +83.0% | 315,331 | 0.0% | 3.20% | +45.1% |
| Q4 2018 | $6,723,000 | -46.1% | 315,331 | 0.0% | 2.21% | -19.9% |
| Q3 2018 | $12,484,000 | +3.6% | 315,331 | 0.0% | 2.76% | +6.2% |
| Q2 2018 | $12,049,000 | +27.2% | 315,331 | 0.0% | 2.60% | +25.7% |
| Q1 2018 | $9,476,000 | +735.6% | 315,331 | +373.8% | 2.06% | +374.7% |
| Q1 2017 | $1,134,000 | -6.7% | 66,553 | 0.0% | 0.44% | -17.6% |
| Q4 2016 | $1,216,000 | +2.6% | 66,553 | 0.0% | 0.53% | -4.7% |
| Q3 2016 | $1,185,000 | – | 66,553 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,485,000 | $69,804,000 | 6.41% |
| Versant Venture Management, LLC | 553,916 | $15,559,500,000 | 6.02% |
| Foresite Capital Management III, LLC | 315,331 | $8,858,000 | 3.38% |
| Opaleye Management Inc. | 285,000 | $8,006,000 | 2.90% |
| Redmile Group, LLC | 2,962,655 | $83,221,000 | 2.78% |
| Casdin Capital, LLC | 860,000 | $24,157,400,000 | 2.50% |
| Sofinnova Investments, Inc. | 933,640 | $26,226,000 | 2.37% |
| Eversept Partners, LP | 253,726 | $7,127,163 | 2.21% |
| PFM Health Sciences, LP | 2,315,938 | $65,055,000 | 1.92% |
| Global Endowment Management, LP | 581,488 | $16,334,000 | 1.43% |